Mode
Text Size
Log in / Sign up

Full-fat dairy vs. low-fat dairy with energy restriction for weight and metabolic outcomes in adults with overweight/obesity

Full-fat dairy vs. low-fat dairy with energy restriction for weight and metabolic outcomes in adults…
Photo by Maria Kovalets / Unsplash
Key Takeaway
Note small RCT shows modest, distinct effects of full-fat dairy vs. energy restriction diets in overweight adults.

This 12-week randomized controlled trial enrolled 74 adults with overweight or obesity. Participants were assigned to either consume three daily servings of full-fat dairy or follow a low-fat dairy energy restriction (LD-ER) diet, which involved a 500 kcal restriction with ≤1 serving of low-fat dairy. The primary outcome was not reported; numerous secondary outcomes related to body composition, metabolism, and dietary intake were assessed.

Main results showed that body weight and BMI were reduced in the LD-ER group over 12 weeks (P < 0.05 for treatment effect). In the full-fat dairy group, hip circumference decreased by 0.25 ± 0.34 cm and systolic blood pressure decreased by 2.72 ± 2.18 mm Hg at week 12 (P < 0.05 for both). Triglycerides increased in all groups at week 4 (P < 0.05) but returned to baseline by week 12. Waist circumference, fat mass, fat-free mass, resting metabolic rate, and fasting blood cholesterol were not affected by treatment or time (P > 0.05). Protein and calcium intakes increased over time in the full-fat dairy groups (P < 0.04), and compliance with Canada's Food Guide reached 77% by week 12.

Safety and tolerability data were not reported. Key limitations include the small sample size (n=74), short 12-week duration, lack of a reported primary outcome, and absence of safety data. The study setting was also not reported. The restrained practice relevance is that this small, short-term trial suggests different dietary approaches may have distinct, modest effects on specific anthropometric and metabolic parameters, but these findings are preliminary and do not establish superiority of one approach for weight loss.

Study Details

Study typeRct
Sample sizen = 74
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Habitual dairy consumption reduces risk factors for obesity and its associated characteristics of the metabolic syndrome. OBJECTIVES: This study aims to describe the effect of adding 3 daily servings of full-fat dairy to the diet of adults with overweight and obesity, counseled to follow Canada's Food Guide (CFG). METHODS: A 12-wk single-blinded, parallel, randomized study was conducted in 74 participants [age: 36.55 ± 1.04 y; body mass index (BMI): 29.34 ± 0.43 kg/m] assigned to 1 of 3 groups: 1) low dairy energy restriction (LD-ER): 500 kcal restriction with ≤1 serving of low-fat dairy, 2) 3 dairy energy neutral (3D-EN): 500 kcal restriction replaced by 3 servings of full-fat dairy, and 3) 3 dairy ad libitum (3D-AL): no energy restriction with 3 servings of full-fat dairy. Changes in physiological outcomes and dietary intakes were measured over 12 wk. RESULTS: Body weight and BMI were reduced by treatment (P < 0.05) in LD-ER over the 12 wk (P > 0.05). In 3D-AL, a decrease (0.25 ± 0.34 cm) in hip circumference (P < 0.05) and in systolic blood pressure (2.72 ± 2.18; P < 0.05; SBP) was found at week 12. SBP also decreased in LD-ER (P < 0.05). Triglycerides increased in all groups at week 4 (P < 0.05) but returned to baseline by week 12. Neither treatment nor time affected waist circumference, fat and fat-free mass, resting metabolic rate, fasting blood cholesterol, and urine creatinine and urea (P > 0.05). Protein and calcium (P < 0.04) intakes were increased with time in 3D-EN and 3D-AL but not in LD-ER. Compliance with CFG, assessed by a food tracker, increased with time (77% by week 12). CONCLUSIONS: Frequent and daily consumption of full-fat dairy as part of a healthy diet is consistent with CFG. This study was registered at clinicaltrials.gov as NCT04399460 on 22 May, 2020 (https://www. CLINICALTRIALS: gov/study/NCT04399460).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.